Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
Mary P. McGowan, Seyed Hamed Hosseini Dehkordi, Patrick M. Moriarty, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 24
Open Access | Times Cited: 204

Showing 1-25 of 204 citing articles:

Evinacumab in Patients with Refractory Hypercholesterolemia
Robert S. Rosenson, Lesley Burgess, Christoph Ebenbichler, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 24, pp. 2307-2319
Open Access | Times Cited: 247
RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies
Gavin M. Traber, Ai‐Ming Yu
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 133-154
Open Access | Times Cited: 171
Lipid Metabolism, Disorders and Therapeutic Drugs - Review
Natesan Vijayakumar, Sung‐Jin Kim
Biomolecules & Therapeutics (2021) Vol. 29, Iss. 6, pp. 596-604
Open Access | Times Cited: 104
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia
Gerald F. Watts, David Sullivan, David L. Hare, et al.
Heart Lung and Circulation (2020) Vol. 30, Iss. 3, pp. 324-349
Open Access | Times Cited: 81
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association
Bruce A. Warden, John R. Guyton, Adrienne C Kovacs, et al.
Journal of clinical lipidology (2022) Vol. 17, Iss. 1, pp. 19-39
Open Access | Times Cited: 63
Familial Hypercholesterolemia: Global Burden and Approaches
Lâle Tokgözoğlu, Meral Kayıkçıoğlu
Current Cardiology Reports (2021) Vol. 23, Iss. 10
Closed Access | Times Cited: 60
Recent Advances on Familial Hypercholesterolemia in Children and Adolescents
Francesca Mainieri, Veronica Maria Tagi, Francesco Chiarelli
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1043-1043
Open Access | Times Cited: 41
Hyperlipidemia and Cardiovascular Risk in Children and Adolescents
Francesca Mainieri, Saverio La Bella, Francesco Chiarelli
Biomedicines (2023) Vol. 11, Iss. 3, pp. 809-809
Open Access | Times Cited: 29
The Growing Class of Novel RNAi Therapeutics
Gavin M. Traber, Ai‐Ming Yu
Molecular Pharmacology (2024) Vol. 106, Iss. 1, pp. 13-20
Open Access | Times Cited: 13
Exploring the potential of cashew waste for food and health applications- A review
Nabila Aslam, Syed Ali Hassan, Fakiha Mehak, et al.
Future Foods (2024) Vol. 9, pp. 100319-100319
Open Access | Times Cited: 12
Screening for Subclinical Atherosclerosis in Patients with Familial Hypercholesterolemia: Insights and Implications
Muhammed Furkan Deniz, Barış Güven, Abdullah Ömer Ebeoğlu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 656-656
Open Access | Times Cited: 1
Cascade Screening of a Pakistani Consanguineous Familial Hypercholesterolemia Cohort: Identification of Seven New Homozygous Patients
Quratul Ain, Jaka Šikonja, Fouzia Sadiq, et al.
Atherosclerosis (2025), pp. 119118-119118
Closed Access | Times Cited: 1
Comparison of Current International Guidelines for the Management of Dyslipidemia
Sevda Aygün, Lâle Tokgözoğlu
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7249-7249
Open Access | Times Cited: 36
Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices
Nuntakorn Thongtang, Renan Sukmawan, Elmer Jasper B. Llanes, et al.
Preventive Medicine Reports (2022) Vol. 27, pp. 101819-101819
Open Access | Times Cited: 33
Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology
Charles German, Seth J. Baum, Keith C. Ferdinand, et al.
American Journal of Preventive Cardiology (2022) Vol. 12, pp. 100432-100432
Open Access | Times Cited: 32
Association of the Interaction Between Familial Hypercholesterolemia Variants and Adherence to a Healthy Lifestyle With Risk of Coronary Artery Disease
Akl C. Fahed, Minxian Wang, Aniruddh P. Patel, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222687-e222687
Open Access | Times Cited: 29
Statins in Children, an Update
Riccardo Fiorentino, Francesco Chiarelli
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1366-1366
Open Access | Times Cited: 19
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
P. Barton Duell, Maciej Banach, Alberico L. Catapano, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 2, pp. e153-e165
Open Access | Times Cited: 6
Familial Hypercholesterolemia and Its Current Diagnostics and Treatment Possibilities: A Literature Analysis
Kristina Zubielienė, Gintarė Valterytė, Neda Jonaitienė, et al.
Medicina (2022) Vol. 58, Iss. 11, pp. 1665-1665
Open Access | Times Cited: 27
Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia
Robert S. Rosenson, Lesley Burgess, Christoph Ebenbichler, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 11, pp. 1070-1070
Open Access | Times Cited: 15
Subclinical Atherosclerosis to Guide Treatment in Dyslipidemia and Diabetes Mellitus
Reed Mszar, Miriam Katz, Gowtham R. Grandhi, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 6, pp. 217-230
Closed Access | Times Cited: 6
Potentials of artificial intelligence in familial hypercholesterolemia: Advances in screening, diagnosis, and risk stratification for early intervention and treatment
Mohammad Athar
International Journal of Cardiology (2024) Vol. 412, pp. 132315-132315
Closed Access | Times Cited: 6
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry
Fotios Barkas, Christos V. Rizos, Georgé Liamis, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 3, pp. e394-e402
Closed Access | Times Cited: 5
Unveiling Familial Hypercholesterolemia—Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy
Piotr Fularski, Joanna Hajdys, Gabriela Majchrowicz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1637-1637
Open Access | Times Cited: 5
Low adherence to statin treatment during the 1st year after an acute myocardial infarction is associated with increased 2nd-year mortality risk—an inverse probability of treatment weighted study on 54 872 patients
Kani Khalaf, Kristina Johnell, Peter C. Austin, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2020) Vol. 7, Iss. 2, pp. 141-147
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top